Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-196a-5p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 1466, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
FOXO1 hsa-miR-196a-5p low: 5 high: 0 3 4 2 0.594
Low-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Liu Xiang-hua et al. 2012 WB qP Lung SPCA1 N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 7.0
UNKNOWN qPCR POSITIVE INDIRECT TarBase 7.0
Liu Xiang-hua et al. 2012 WB qP Lung A549 N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 7.0
UNKNOWN qPCR POSITIVE INDIRECT TarBase 7.0
Liu Xiang-hua et al. 2012 RP Lung NSCLC HEK293T N/A
Location Method Result Regulation Validation Type Source
chr13:40558572-40558594 Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
et al. O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
Helwak Aleksandra et al. 2013 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
NFKBIA hsa-miR-196a-5p low: 2 high: 2 3 4 4 -
Low-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Huang F et al. 2014 RP Pancreas Pancreatic Cancer Cell Lines PANC1 N/A
Location Method Result Regulation Validation Type Source
chr14:35401616-35401637 Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
Huang F et al. 2014 WB Pancreas Pancreatic Cancer Cell Lines N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 7.0
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr14:35402819-35402841 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr14:35402819-35402841 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
Huang F et al. 2014 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
HOX-C8(hsa) hsa-miR-196a-5p low: 2 high: 0 1 1 1 -
Low-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Daniel W Mueller et al. 2011 WB qP N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 6.0
UNKNOWN qPCR POSITIVE INDIRECT TarBase 6.0
CDKN1B hsa-miR-196a-5p low: 1 high: 7 5 7 5 0.757
Low-throughput experiments (0 positive, 1 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Carlos le Sage et al. 2007 RP Mammary Gland MCF7 MCF7 N/A
Location Method Result Regulation Validation Type Source
chr12:12721054-12722332 Luciferase Reporter Assay NEGATIVE DIRECT TarBase 8.0
High-throughput experiments (7 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Grosswendt S et al. 2014 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:12721258-12721285 Chimeric fragments POSITIVE DIRECT TarBase 8.0
chr12:12722115-12722144 Chimeric fragments POSITIVE DIRECT TarBase 8.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr12:12721253-12721279 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr12:12721253-12721279 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:12721253-12721279 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:12721253-12721279 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:12721253-12721279 PAR-CLIP POSITIVE DIRECT TarBase 7.0
HMGA2 hsa-miR-196a-5p low: 1 high: 4 5 5 3 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Palmieri D. et al. 2012 RP Bone Marrow MEG01 MEG01 N/A
Location Method Result Regulation Validation Type Source
chr12:65964469-65965862 Luciferase Reporter Assay POSITIVE DIRECT TarBase 8.0
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Grosswendt S et al. 2014 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:65965794-65965819 Chimeric fragments POSITIVE DIRECT TarBase 8.0
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr12:65965798-65965818 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr12:65964532-65964553 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr12:65964532-65964553 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HOXA5 hsa-miR-196a-5p low: 1 high: 2 4 3 3 0.998
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Liu Xiang-hua et al. 2012 RP Lung NSCLC HEK293T N/A
Location Method Result Regulation Validation Type Source
chr7:27141387-27141408 Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Grosswendt S et al. 2014 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:27141384-27141408 Chimeric fragments POSITIVE DIRECT TarBase 8.0
Kishore S et al. 2011 IP Kidney HEK293 N/A mild MNase digestion
Location Method Result Regulation Validation Type Source
chr7:27141387-27141415 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
Sebastian Memczak et al. 2013 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
Liu Xiang-hua et al. 2012 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
CDK6 hsa-miR-196a-5p low: 1 high: 1 2 2 2 0.550
Low-throughput experiments (0 positive, 1 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Huang F et al. 2014 WB Pancreas Pancreatic Cancer Cell Lines N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot NEGATIVE INDIRECT TarBase 7.0
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr7:92613151-92613173 PAR-CLIP POSITIVE DIRECT TarBase 7.0
CCND1 hsa-miR-196a-5p low: 1 high: 0 2 2 2 -
Low-throughput experiments (0 positive, 1 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Huang F et al. 2014 WB Pancreas Pancreatic Cancer Cell Lines N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot NEGATIVE INDIRECT TarBase 7.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
Helwak Aleksandra et al. 2013 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
ANXA1 hsa-miR-196a-5p low: 1 high: 0 1 2 2 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
R Luthra et al. 2008 RP Mammary Gland MCF7 MCF7 N/A
Location Method Result Regulation Validation Type Source
chr9:73170198-73170217 Luciferase Reporter Assay POSITIVE DIRECT TarBase 6.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
R Luthra et al. 2008 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
cadherin-1(hsa) hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Daniel W Mueller et al. 2011 qP N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN qPCR POSITIVE INDIRECT TarBase 6.0
calponin-1(hsa) hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Daniel W Mueller et al. 2011 qP N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN qPCR POSITIVE INDIRECT TarBase 6.0
VIM hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (0 positive, 1 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Huang F et al. 2014 WB Pancreas Pancreatic Cancer Cell Lines N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot NEGATIVE INDIRECT TarBase 7.0
CDH1 hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Huang F et al. 2014 WB Pancreas Pancreatic Cancer Cell Lines N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 7.0
GNPDA1 hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 WB Cervix HELA N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 7.0
CDK4 hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (0 positive, 1 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Huang F et al. 2014 WB Pancreas Pancreatic Cancer Cell Lines N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot NEGATIVE INDIRECT TarBase 7.0
CDH2 hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (0 positive, 1 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Huang F et al. 2014 WB Pancreas Pancreatic Cancer Cell Lines N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot NEGATIVE INDIRECT TarBase 7.0
Hugl-1(hsa) hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Daniel W Mueller et al. 2011 qP N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN qPCR POSITIVE INDIRECT TarBase 6.0
osteopontin(hsa) hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Daniel W Mueller et al. 2011 qP N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN qPCR POSITIVE INDIRECT TarBase 6.0
HMGA1 hsa-miR-196a-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Palmieri D. et al. 2012 RP Bone Marrow MEG01 MEG01 N/A
Location Method Result Regulation Validation Type Source
chr6:34245848-34246188 Luciferase Reporter Assay POSITIVE DIRECT TarBase 8.0
MT-ND5 hsa-miR-196a-5p low: 0 high: 7 3 3 3 -
High-throughput experiments (7 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Grosswendt S et al. 2014 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chrMT:13811-13837 Chimeric fragments POSITIVE DIRECT TarBase 8.0
Moore M et al. 2015 IP Liver HUH7.5 N/A N/A
Location Method Result Regulation Validation Type Source
chrMT:13229-13304 CLEAR-CLIP POSITIVE DIRECT TarBase 8.0
chrMT:13758-13833 CLEAR-CLIP POSITIVE DIRECT TarBase 8.0
chrMT:13552-13695 CLEAR-CLIP POSITIVE DIRECT TarBase 8.0
chrMT:13083-13158 CLEAR-CLIP POSITIVE DIRECT TarBase 8.0
chrMT:12680-12755 CLEAR-CLIP POSITIVE DIRECT TarBase 8.0
chrMT:12492-12567 CLEAR-CLIP POSITIVE DIRECT TarBase 8.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
Helwak Aleksandra et al. 2013 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase